Dr. Reddy's New Corporate Identity
|
|
ICMR HOME | Case Studies Collection
Case Details:
Case Code : BSTR013
Case Length : 9 Pages
Period : 2000-2001
Organization : Dr. Reddy Labs, American Remedies Ltd, Cheminor Drugs Ltd.
Pub Date : 2002
Teaching Note : Available
Countries : India
Industry : Healthcare & Pharmaceuticals
To download Dr. Reddy's New Corporate Identity case study (Case Code: BSTR013) click on the button below, and select the case from the list of available cases:
Price:
For delivery in electronic format: Rs. 300 ;
For delivery through courier (within India): Rs. 300 + Rs. 25 for Shipping & Handling Charges
»
Business Strategy Case Studies
» Business Strategy Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Area Specific Case Studies
» Industry Wise Case Studies
» Company Wise Case Studies
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
|
|
<< Previous
"In 1999, we got the critical mass and the feeling within the company was that we had arrived. We were close to the Rs 1,000-crore mark in turnover, which called for a new way of looking at things and taking the message to the stakeholders."
- Satish Reddy Chief Operating Officer, Dr. Reddy's Laboratories.
"The new identity highlights the company's ethos - a caring organization that leverages its expertise in research for a healthier life."
- Dr. K. Anji Reddy, Chairman, Dr. Reddy's Laboratories.
Introduction
On April 26, 2001, Dr. Reddy's Laboratories (DRL) unveiled its new corporate identity and philosophy, reinforcing its commitment to bring hope to life through meaningful research. (Refer Exhibit I) It unveiled a new logo, new colors, (Refer Exhibit II) a code of conduct for employees, a Dr. Reddy's anthem and the new base line - Life, Research, Hope.
|
DRL had changed its corporate identity for the second time in less than a decade.1 This was despite the fact that DRL already had a well-defined, widely recognized identity. Analysts felt that the change in corporate identity was necessary as DRL was targeting the global market.
DRL officials felt that the company needed a corporate image that was more in tune with its international profile. The new corporate identity was forged from the merger of DRL, Cheminor Drugs Ltd. (CDL)2 and American Remedies Ltd. (ARL)3 into a homogenous unit in 2000 and DRL's subsequent listing on New York Stock Exchange (NYSE) in 2001.
|
|
Background Note
DRL was founded in 1984 by Dr. K. Anji Reddy (Dr. Reddy) to create and deliver innovative pharmaceutical healthcare solutions.
|
|
DRL became a public limited company in 1985 and had an IPO of equity linked debentures aggregating Rs.24.6 million in May 1986. During the 1990s, the company consolidated its position in the domestic formulations market through aggressive product launches as well as acquisitions.
By late 1990s, DRL transformed itself into a global pharmaceutical powerhouse with research and drug development as its strengths. DRL's operations were divided into six divisions including branded finished dosage, generic finished dosage, bulk actives, custom chemicals, biotechnology and diagnostics (Refer Exhibit III)... |
Dr. Reddy's New Corporate Identity
- Next Page>>
|
|
